English
简体中文
Total: £ 56.28
Published Date: 2025-04-23 | Pages: 98 | Tables: 96 | Medical Care
The global Transcatheter Aortic Valve Replacement (TAVR) market size was US$ 8771 million in 2024 and is forecast to a readjusted size of US$ 17790 million by 2031 with a CAGR of 10.8% during the forecast period 2025-2031.
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
The Transcatheter Aortic Valve Replacement (TAVR) market is primarily driven by the increasing prevalence of aortic stenosis and the growing aging population worldwide. As people live longer, the incidence of age-related cardiovascular conditions, such as aortic valve disease, is on the rise. TAVR offers a minimally invasive alternative to traditional open-heart surgery, making it a highly attractive option for elderly patients or those with high surgical risk. Additionally, technological advancements in TAVR devices, such as improved valve designs, delivery systems, and procedural techniques, have contributed to enhanced patient outcomes and safety, further expanding the market. The increasing acceptance of TAVR as a first-line treatment, even for intermediate-risk patients, also fuels market growth.
However, the TAVR market faces several challenges, primarily the high cost of the procedure and devices. Despite its advantages, TAVR is still a relatively expensive treatment, which can limit its accessibility, particularly in low- and middle-income countries or healthcare systems with constrained budgets. Furthermore, the long-term durability of TAVR valves remains a concern for both physicians and patients, as the procedure is relatively new compared to traditional surgical valve replacements. Ongoing research and clinical trials are needed to better understand the long-term outcomes of TAVR, which could influence its adoption and cost-effectiveness in the future.
Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, etc. are the leaders of the industry, Top 5 compnay market share are about 90%
The global Transcatheter Aortic Valve Replacement (TAVR) market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
Venus Medtech
Bracco (HLT)
JenaValve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
MicroPort
By Type: (Dominant Segment vs High-Margin Innovation)
Transfemoral Approach
Transapical Approach
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Aortic Stenosis
Aortic Regurgitation
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Edwards Lifesciences in Europe)
- Emerging Product Trends: Transfemoral Approach adoption vs. Transapical Approach premiumization
- Demand-Side Dynamics: Aortic Stenosis growth in China vs. Aortic Regurgitation potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
India
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Transcatheter Aortic Valve Replacement (TAVR) market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Transapical Approach in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Aortic Regurgitation in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Transcatheter Aortic Valve Replacement (TAVR) value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Transfemoral Approach
1.2.3 Transapical Approach
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Aortic Stenosis
1.3.3 Aortic Regurgitation
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Region (2020-2025)
2.4 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size and Prospective (2020-2031)
2.5.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size and Prospective (2020-2031)
2.5.3 China Transcatheter Aortic Valve Replacement (TAVR) Market Size and Prospective (2020-2031)
2.5.4 India Transcatheter Aortic Valve Replacement (TAVR) Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Transcatheter Aortic Valve Replacement (TAVR) Historic Market Size by Type (2020-2025)
3.2 Global Transcatheter Aortic Valve Replacement (TAVR) Forecasted Market Size by Type (2026-2031)
3.3 Different Types Transcatheter Aortic Valve Replacement (TAVR) Representative Players
4 Breakdown Data by Application
4.1 Global Transcatheter Aortic Valve Replacement (TAVR) Historic Market Size by Application (2020-2025)
4.2 Global Transcatheter Aortic Valve Replacement (TAVR) Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Transcatheter Aortic Valve Replacement (TAVR) Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Transcatheter Aortic Valve Replacement (TAVR) Players by Revenue (2020-2025)
5.1.2 Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Transcatheter Aortic Valve Replacement (TAVR) Revenue
5.4 Global Transcatheter Aortic Valve Replacement (TAVR) Market Concentration Analysis
5.4.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Transcatheter Aortic Valve Replacement (TAVR) Revenue in 2024
5.5 Global Key Players of Transcatheter Aortic Valve Replacement (TAVR) Head office and Area Served
5.6 Global Key Players of Transcatheter Aortic Valve Replacement (TAVR), Product and Application
5.7 Global Key Players of Transcatheter Aortic Valve Replacement (TAVR), Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type (2020-2025)
6.1.2.2 North America Transcatheter Aortic Valve Replacement (TAVR) Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application (2020-2025)
6.1.3.2 North America Transcatheter Aortic Valve Replacement (TAVR) Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type (2020-2025)
6.2.2.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application (2020-2025)
6.2.3.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type (2020-2025)
6.3.2.2 China Transcatheter Aortic Valve Replacement (TAVR) Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application (2020-2025)
6.3.3.2 China Transcatheter Aortic Valve Replacement (TAVR) Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 India Market: Players, Segments and Downstream
6.4.1 India Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2020-2025)
6.4.2 India Market Size by Type
6.4.2.1 India Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type (2020-2025)
6.4.2.2 India Transcatheter Aortic Valve Replacement (TAVR) Market Share by Type (2020-2025)
6.4.3 India Market Size by Application
6.4.3.1 India Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application (2020-2025)
6.4.3.2 India Transcatheter Aortic Valve Replacement (TAVR) Market Share by Application (2020-2025)
6.4.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 Edwards Lifesciences
7.1.1 Edwards Lifesciences Company Details
7.1.2 Edwards Lifesciences Business Overview
7.1.3 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Introduction
7.1.4 Edwards Lifesciences Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
7.1.5 Edwards Lifesciences Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Details
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Introduction
7.2.4 Medtronic Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
7.2.5 Medtronic Recent Development
7.3 Abbott
7.3.1 Abbott Company Details
7.3.2 Abbott Business Overview
7.3.3 Abbott Transcatheter Aortic Valve Replacement (TAVR) Introduction
7.3.4 Abbott Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
7.3.5 Abbott Recent Development
7.4 Boston Scientific
7.4.1 Boston Scientific Company Details
7.4.2 Boston Scientific Business Overview
7.4.3 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Introduction
7.4.4 Boston Scientific Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
7.4.5 Boston Scientific Recent Development
7.5 Meril Life Sciences
7.5.1 Meril Life Sciences Company Details
7.5.2 Meril Life Sciences Business Overview
7.5.3 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Introduction
7.5.4 Meril Life Sciences Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
7.5.5 Meril Life Sciences Recent Development
7.6 Venus Medtech
7.6.1 Venus Medtech Company Details
7.6.2 Venus Medtech Business Overview
7.6.3 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Introduction
7.6.4 Venus Medtech Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
7.6.5 Venus Medtech Recent Development
7.7 Bracco (HLT)
7.7.1 Bracco (HLT) Company Details
7.7.2 Bracco (HLT) Business Overview
7.7.3 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Introduction
7.7.4 Bracco (HLT) Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
7.7.5 Bracco (HLT) Recent Development
7.8 JenaValve Technology
7.8.1 JenaValve Technology Company Details
7.8.2 JenaValve Technology Business Overview
7.8.3 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Introduction
7.8.4 JenaValve Technology Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
7.8.5 JenaValve Technology Recent Development
7.9 Suzhou Jiecheng Medical Technology Co.
7.9.1 Suzhou Jiecheng Medical Technology Co. Company Details
7.9.2 Suzhou Jiecheng Medical Technology Co. Business Overview
7.9.3 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Introduction
7.9.4 Suzhou Jiecheng Medical Technology Co. Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
7.9.5 Suzhou Jiecheng Medical Technology Co. Recent Development
7.10 Peijia Medical
7.10.1 Peijia Medical Company Details
7.10.2 Peijia Medical Business Overview
7.10.3 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Introduction
7.10.4 Peijia Medical Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
7.10.5 Peijia Medical Recent Development
7.11 MicroPort
7.11.1 MicroPort Company Details
7.11.2 MicroPort Business Overview
7.11.3 MicroPort Transcatheter Aortic Valve Replacement (TAVR) Introduction
7.11.4 MicroPort Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
7.11.5 MicroPort Recent Development
8 Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics
8.1 Transcatheter Aortic Valve Replacement (TAVR) Industry Trends
8.2 Transcatheter Aortic Valve Replacement (TAVR) Market Drivers
8.3 Transcatheter Aortic Valve Replacement (TAVR) Market Challenges
8.4 Transcatheter Aortic Valve Replacement (TAVR) Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Transcatheter Aortic Valve Replacement (TAVR) Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Share by Region (2020-2025)
Table 6. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Share Forecast by Region (2026-2031)
Table 8. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2020-2025)
Table 10. Global Transcatheter Aortic Valve Replacement (TAVR) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2020-2025)
Table 15. Global Transcatheter Aortic Valve Replacement (TAVR) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Transcatheter Aortic Valve Replacement (TAVR) Application
Table 18. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Transcatheter Aortic Valve Replacement (TAVR) Market Share by Players (2020-2025)
Table 20. Global Top Transcatheter Aortic Valve Replacement (TAVR) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcatheter Aortic Valve Replacement (TAVR) as of 2024)
Table 21. Ranking of Global Top Transcatheter Aortic Valve Replacement (TAVR) Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Transcatheter Aortic Valve Replacement (TAVR) Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Transcatheter Aortic Valve Replacement (TAVR), Headquarters and Area Served
Table 24. Global Key Players of Transcatheter Aortic Valve Replacement (TAVR), Product and Application
Table 25. Global Key Players of Transcatheter Aortic Valve Replacement (TAVR), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Company (2020-2025)
Table 29. North America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Company (2020-2025)
Table 33. Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Company (2020-2025)
Table 37. China Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application (2020-2025) & (US$ Million)
Table 39. India Transcatheter Aortic Valve Replacement (TAVR) Revenue by Company (2020-2025) & (US$ Million)
Table 40. India Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Company (2020-2025)
Table 41. India Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type (2020-2025) & (US$ Million)
Table 42. India Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application (2020-2025) & (US$ Million)
Table 43. Edwards Lifesciences Company Details
Table 44. Edwards Lifesciences Business Overview
Table 45. Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Product
Table 46. Edwards Lifesciences Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025) & (US$ Million)
Table 47. Edwards Lifesciences Recent Development
Table 48. Medtronic Company Details
Table 49. Medtronic Business Overview
Table 50. Medtronic Transcatheter Aortic Valve Replacement (TAVR) Product
Table 51. Medtronic Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025) & (US$ Million)
Table 52. Medtronic Recent Development
Table 53. Abbott Company Details
Table 54. Abbott Business Overview
Table 55. Abbott Transcatheter Aortic Valve Replacement (TAVR) Product
Table 56. Abbott Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025) & (US$ Million)
Table 57. Abbott Recent Development
Table 58. Boston Scientific Company Details
Table 59. Boston Scientific Business Overview
Table 60. Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Product
Table 61. Boston Scientific Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025) & (US$ Million)
Table 62. Boston Scientific Recent Development
Table 63. Meril Life Sciences Company Details
Table 64. Meril Life Sciences Business Overview
Table 65. Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Product
Table 66. Meril Life Sciences Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025) & (US$ Million)
Table 67. Meril Life Sciences Recent Development
Table 68. Venus Medtech Company Details
Table 69. Venus Medtech Business Overview
Table 70. Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Product
Table 71. Venus Medtech Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025) & (US$ Million)
Table 72. Venus Medtech Recent Development
Table 73. Bracco (HLT) Company Details
Table 74. Bracco (HLT) Business Overview
Table 75. Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Product
Table 76. Bracco (HLT) Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025) & (US$ Million)
Table 77. Bracco (HLT) Recent Development
Table 78. JenaValve Technology Company Details
Table 79. JenaValve Technology Business Overview
Table 80. JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Product
Table 81. JenaValve Technology Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025) & (US$ Million)
Table 82. JenaValve Technology Recent Development
Table 83. Suzhou Jiecheng Medical Technology Co. Company Details
Table 84. Suzhou Jiecheng Medical Technology Co. Business Overview
Table 85. Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Product
Table 86. Suzhou Jiecheng Medical Technology Co. Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025) & (US$ Million)
Table 87. Suzhou Jiecheng Medical Technology Co. Recent Development
Table 88. Peijia Medical Company Details
Table 89. Peijia Medical Business Overview
Table 90. Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Product
Table 91. Peijia Medical Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025) & (US$ Million)
Table 92. Peijia Medical Recent Development
Table 93. MicroPort Company Details
Table 94. MicroPort Business Overview
Table 95. MicroPort Transcatheter Aortic Valve Replacement (TAVR) Product
Table 96. MicroPort Revenue in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025) & (US$ Million)
Table 97. MicroPort Recent Development
Table 98. Transcatheter Aortic Valve Replacement (TAVR) Market Trends
Table 99. Transcatheter Aortic Valve Replacement (TAVR) Market Drivers
Table 100. Transcatheter Aortic Valve Replacement (TAVR) Market Challenges
Table 101. Transcatheter Aortic Valve Replacement (TAVR) Market Restraints
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Transcatheter Aortic Valve Replacement (TAVR) Product Picture
Figure 2. Global Transcatheter Aortic Valve Replacement (TAVR) Market Share by Type: 2024 VS 2031
Figure 3. Transfemoral Approach Features
Figure 4. Transapical Approach Features
Figure 5. Others Features
Figure 6. Global Transcatheter Aortic Valve Replacement (TAVR) Market Share by Application: 2024 VS 2031
Figure 7. Aortic Stenosis
Figure 8. Aortic Regurgitation
Figure 9. Others
Figure 10. Transcatheter Aortic Valve Replacement (TAVR) Report Years Considered
Figure 11. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Transcatheter Aortic Valve Replacement (TAVR) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Transcatheter Aortic Valve Replacement (TAVR) Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. India Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Transcatheter Aortic Valve Replacement (TAVR) Market Share by Players in 2024
Figure 19. Global Top Transcatheter Aortic Valve Replacement (TAVR) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcatheter Aortic Valve Replacement (TAVR) as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Transcatheter Aortic Valve Replacement (TAVR) Revenue in 2024
Figure 21. North America Transcatheter Aortic Valve Replacement (TAVR) Market Share by Type (2020-2025)
Figure 22. North America Transcatheter Aortic Valve Replacement (TAVR) Market Share by Application (2020-2025)
Figure 23. Europe Transcatheter Aortic Valve Replacement (TAVR) Market Share by Type (2020-2025)
Figure 24. Europe Transcatheter Aortic Valve Replacement (TAVR) Market Share by Application (2020-2025)
Figure 25. China Transcatheter Aortic Valve Replacement (TAVR) Market Share by Type (2020-2025)
Figure 26. China Transcatheter Aortic Valve Replacement (TAVR) Market Share by Application (2020-2025)
Figure 27. India Transcatheter Aortic Valve Replacement (TAVR) Market Share by Type (2020-2025)
Figure 28. India Transcatheter Aortic Valve Replacement (TAVR) Market Share by Application (2020-2025)
Figure 29. Edwards Lifesciences Revenue Growth Rate in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
Figure 30. Medtronic Revenue Growth Rate in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
Figure 31. Abbott Revenue Growth Rate in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
Figure 32. Boston Scientific Revenue Growth Rate in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
Figure 33. Meril Life Sciences Revenue Growth Rate in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
Figure 34. Venus Medtech Revenue Growth Rate in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
Figure 35. Bracco (HLT) Revenue Growth Rate in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
Figure 36. JenaValve Technology Revenue Growth Rate in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
Figure 37. Suzhou Jiecheng Medical Technology Co. Revenue Growth Rate in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
Figure 38. Peijia Medical Revenue Growth Rate in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
Figure 39. MicroPort Revenue Growth Rate in Transcatheter Aortic Valve Replacement (TAVR) Business (2020-2025)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed
